Understanding how AB-PINACA interacts with cannabinoid receptors can provide insights into possible therapeutic applications along with the mechanisms of cannabinoid-associated Problems.AB-PINACA is classed to be a synthetic cannabinoid receptor agonist, this means it binds to CB1 and CB2 receptors to mimic the results of all-natural cannabinoids.